Diatech Pharmacogenetics is pleased to announce its participation in the cascade funding calls within the ECOSYSTEM VITALITY – INNOVATIVE THERAPEUTIC APPROACHES: NEW CHEMICAL ENTITIES, BIOLOGICS AND DRUG DELIVERY, SPOKE 8, with a project aimed at developing a genetic passport for pharmacogenetics based on Next Generation Sequencing.
CASCADE CALL – ECOSYSTEM VITALITY – INNOVATIVE THERAPEUTIC APPROACHES: NEW CHEMICAL ENTITIES, BIOLOGICS AND DRUG DELIVERY, SPOKE 8
Next Generation EU – PNRR – Innovation Ecosystems – Mission 4 Education and Research – Component 2 From Research to Business – Investment 1.5, funded by the European Union
– University of Urbino Carlo Bo
CUP H33C22000430006